Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: USFD stock price vs ABBV: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ABBV's multiple
Needs ABBV P/E.
Implied fair value · at USFD's multiple
Needs USFD P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
US FOODS HOLDING CORP. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
AbbVie Inc. · implied price per share
Bear
$74.44
Base
$92.88
Bull
$117.70
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
SYSCO CORP
USFD vs SYY
Performance Food Group Co
USFD vs PFGC
GENUINE PARTS CO
USFD vs GPC
UNITED NATURAL FOODS INC
USFD vs UNFI
Pfizer Inc.
USFD vs PFE
Johnson & Johnson
USFD vs JNJ
Merck & Co., Inc.
USFD vs MRK
Eli Lilly and Company
USFD vs LLY
Amgen Inc.
USFD vs AMGN
Gilead Sciences, Inc.
USFD vs GILD
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe USFD can sustain its current margin structure while improving returns and growth, then the shares may merit holding or selective buying because the stock trades at a major discount on revenue-based multiples versus ABBV; if you prioritize profitability and quality, ABBV remains the stronger business on the provided data.
USFD’s current price of $104.29 sits well below ABBV-implied price range and far below the P/E-derived implied price of $325.23, suggesting a large valuation discount versus ABBV. However, that gap is partly explained by USFD’s much weaker margin structure and lower return profile.
Supporting Metrics
